Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-988-1 | CAS number: 26762-93-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Diisopropylbenzene hydroperoxide
- EC Number:
- 247-988-1
- EC Name:
- Diisopropylbenzene hydroperoxide
- Cas Number:
- 26762-93-6
- Molecular formula:
- C12H18O2
- IUPAC Name:
- reaction mass of 1-(3-isopropylphenyl)-1-methylethyl hydroperoxide and 1-(4-isopropylphenyl)-1-methylethyl hydroperoxide
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Test animals:
Species, strain: rat, Sprague-Dawley Rj: SD (IOPS Han).
Reason for this choice: rodent species generally accepted by regulatory authorities for this type of study.
Breeder: Janvier, Le Genest-Saint-Isle, France.
Number and sex: one group of ten animals (five males and five females).
Females were nulliparous and non-pregnant.
Age/weight: on the day of treatment, the animals were approximately 8 weeks old and had a mean body weight ± standard deviation of 312 ± 8 g for the males and 219 ± 8 g for the females.
Acclimation: at least 5 days before the beginning of the study.
Identification: individually by earnotches.
Environmental conditions:
The conditions in the animal room were set as follows:
• temperature: 22 ± 2°C
• relative humidity: 30 to 70%
• light/dark cycle: 12 h/12 h
• ventilation: approximately 12 cycles/hour of filtered, non-recycled air.
• food and water ad libitum
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- On the day before treatment, the dorsal area of each animal was clipped (i.e. approximately 5 cm x 7 cm for males and 5 cm x 6 cm for females) using an electric clipper. Only animals with healthy intact skin were used for the study. The test item was applied undiluted at the dose-level of 2000 mg/kg, taking into consideration that its specific gravity was 0.93 g/mL. The volume of administration was therefore 2.15 mL/kg.
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw for diisopropylbenzene hydroperoxide in its solvent
1118 mg/kg bw for diisopropylbenzene hydroperoxide - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- The animals were observed frequently during the hours following administration of the test item, for detection of possible treatment-related clinical signs. Thereafter, observation of the animals was made at least once a day until day 15.
Type, time of onset and duration of clinical signs were recorded for each animal individually. The animals were weighed individually just before administration of the test item on day 1 and then on days 8 and 15.
The body weight gain of the treated animals was compared to that of CIT control animals with a similar initial body weight. On day 15, all animals were killed by carbon dioxide asphyxiation. All study animals were subjected to a macroscopic examination as soon as possible after death.
After opening the thoracic and abdominal cavities, a macroscopic examination of the main organs (digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organs with obvious abnormalities) was performed.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks:
- Luperox DH
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- 1 118 mg/kg bw
- Based on:
- act. ingr.
- Remarks:
- diisopropylbenzene hydroperoxide
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- other: No systemic clinical signs were observed during the study. Only dryness of the skin was noted in all animals from day 4 up to day 13. No other cutaneous reactions were recorded during the study.
- Gross pathology:
- Macroscopic examination of the main organs of the animals revealed no apparent abnormalities
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD0 of diisopropylbenzene hydroperoxide is higher than 1118 mg/kg in rats.
- Executive summary:
The acute dermal toxicity of Luperox DH (diisopropylbenzene monohydroperoxide at 55.9% in diisopropylbenzene) was evaluated in rats according to OECD N°402 guideline. One groups of 5 male and 5 female Sprague Dawley rats was given a single dermal dose of Luperox DH at doses of 2000 mg/kg (equivalent to 1118 mg/kg of diisopropylbenzene monohydroperoxide). Following treatment, rats were observed daily and weighted weekly. A gross necropsy examination was performed at the time of scheduled euthanasia (Day 14).
No systemic clinical signs and no deaths were observed during the study. Only dryness of the skin was noted in all animals from day 4 up to day 13. No other cutaneous reactions were recorded during the study. A slightly reduced weight gain was seen in 1/5 males and 2/5 females during the second week of the study. The overall body weight gain of the other animals was similar to that of historical control animals. No apparent abnormalities were observed at necropsy in any animal.
Under these experimental conditions, the dermal LD0 in rats of the Luperox DH is higher than 2000 mg/kg (equivalent to 1118 mg/kg of diisopropylbenzene monohydroperoxide).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.